Insider trading

Period: 120 months Stock: STAA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

188 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

188 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

188 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

188 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
188 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
188 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

188 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Jun 2020
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$1.73M 39,215 at 44.07
23.5%
10 Jun 2020
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$34.54K 785 at 44.00
0.6%
21 May 2020
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$7.70M 192,522 at 40.00
82.4%
Sold half or more
15 May 2020
Holliday Keith Chief Technology Officer
Sold, plan not stated
$942.25K 25,000 at 37.69
46.8%
11 May 2020
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$1.82M 46,563 at 39.11
81.2%
Sold half or more
11 May 2020
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$736.52K 18,856 at 39.06
29.8%
11 May 2020
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated 4×
$709.71K 18,189 at 39.02
53.2%
Sold half or more
23 Mar 2020
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated
$77.13K 2,813 at 27.42
12.6%
23 Mar 2020
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$75.47K 2,813 at 26.83
20.7%
23 Mar 2020
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$75.19K 2,742 at 27.42
6.2%
23 Mar 2020
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$60.23K 2,250 at 26.77
4.8%
23 Mar 2020
ANDREWS DEBORAH J Chief Financial Officer
Sold, plan not stated
$22.87K 834 at 27.42
2.6%
21 Jan 2020
ANDREWS DEBORAH J Chief Financial Officer
Sold, plan not stated
$4.50M 106,604 at 42.20
76.9%
Sold half or more
5 Dec 2019
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated 2×
$1.76M 47,408 at 37.20
88.4%
Sold half or more
4 Dec 2019
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated 2×
$1.72M 45,000 at 38.15
26.6%
20 Nov 2019
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated
$598.25K 17,083 at 35.02
67.2%
Sold half or more
14 Nov 2019
ANDREWS DEBORAH J Chief Financial Officer
Sold, plan not stated
$144.51K 4,167 at 34.68
11.5%
14 Nov 2019
Barnes Scott D Chief Medical Officer
Sold, plan not stated
$55.29K 1,583 at 34.93
12.5%
5 Nov 2019
Holliday Keith Chief Technology Officer
Sold, plan not stated
$505.44K 14,441 at 35.00
50.2%
Sold half or more
4 Nov 2019
Holliday Keith Chief Technology Officer
Sold, plan not stated
$73.50K 2,100 at 35.00
6.8%
3 May 2019
Bought
$2.22M 100,000 at 22.23
0.9%
First buy on file
4 Apr 2019
ANDREWS DEBORAH J Chief Financial Officer
Sold, plan not stated
$34.35K 1,000 at 34.35
2.7%
22 Mar 2019
Holliday Keith Chief Technology Officer
Sold, plan not stated
$121.53K 3,125 at 38.89
7.8%
22 Mar 2019
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$65.61K 1,688 at 38.87
4.6%
22 Mar 2019
ANDREWS DEBORAH J Chief Financial Officer
Sold, plan not stated
$32.39K 833 at 38.88
2.2%
19 Mar 2019
Mason Caren L President & CEO
Sold, plan not stated
$271.88K 7,500 at 36.25
14.6%
19 Mar 2019
Holliday Keith Chief Technology Officer
Sold, plan not stated
$75.48K 2,084 at 36.22
4.9%
19 Mar 2019
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$54.30K 1,500 at 36.20
3.9%
20 Aug 2018
Wall William P Director
Sold, plan not stated
$206.75K 5,000 at 41.35
23.5%
3 May 2018
ANDREWS DEBORAH J Chief Financial Officer
Sold, plan not stated
$234.63K 13,331 at 17.60
46.0%
22 Mar 2018
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$45.47K 2,833 at 16.05
6.9%
22 Mar 2018
Holliday Keith Chief Technology Officer
Sold, plan not stated
$35.06K 2,188 at 16.03
4.8%
22 Mar 2018
ANDREWS DEBORAH J Chief Financial Officer
Sold, plan not stated
$5.34K 333 at 16.05
2.1%
20 Mar 2018
Holliday Keith Chief Technology Officer
Sold, plan not stated
$23.40K 1,458 at 16.05
3.1%
19 Mar 2018
Mason Caren L President & CEO
Sold, plan not stated
$107.27K 6,667 at 16.09
11.5%
21 Nov 2017
Holliday Keith V.P., Chief Technology Officer
Sold, plan not stated
$99.92K 6,000 at 16.65
11.5%
9 Dec 2016
Blickensdoerfer Hans-Martin Sr. VP, EMEA, LA and China
Sold, plan not stated
$48.89K 4,320 at 11.32
3.6%
8 Dec 2016
Blickensdoerfer Hans-Martin Sr. VP, EMEA, LA and China
Sold, plan not stated
$229.59K 20,680 at 11.10
15.1%
Showing 151–188 of 188. ← Newer Page 4 of 4